Neoadjuvant multimodal treatment of borderline resectable (BRPC) and locally advanced unresectable pancreatic cancer (LAPC) in Mexico.

被引：0
|
作者：
Rosas Camargo, Vanessa
Martos Armedariz, Edgar Omar
Cisneros Cordero, Miriam Heidi
Nieto Garcia, Zuleyma
Flores Balcazar, Christian Haydee
Meneses Medina, Monica Isabel
Chan Nunez, Carlos
Gamboa Dominguez, Armando
Huitzil Melendez, Fidel David
机构：
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[2] Univ Juarez Estado Durango, Fac Med, Unidad Gomez Palacio, Gomez Palacio, Mexico
[3] Inst Politecn Nacl, Escuela Nacl Med & Homeopatia, Mexico City, DF, Mexico
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.454
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
454
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas
    Blazer, Marlo
    Wu, Christina
    Goldberg, Richard M.
    Phillips, Gary
    Schmidt, Carl
    Muscarella, Peter
    Wuthrick, Evan
    Williams, Terrence M.
    Reardon, Joshua
    Ellison, E. Christopher
    Bloomston, Mark
    Bekaii-Saab, Tanios
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (04) : 1153 - 1159
  • [2] Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas
    Marlo Blazer
    Christina Wu
    Richard M. Goldberg
    Gary Phillips
    Carl Schmidt
    Peter Muscarella
    Evan Wuthrick
    Terrence M. Williams
    Joshua Reardon
    E. Christopher Ellison
    Mark Bloomston
    Tanios Bekaii-Saab
    [J]. Annals of Surgical Oncology, 2015, 22 : 1153 - 1159
  • [3] Borderline resectable (BRPC) and locally advanced unresectable (LAPC) pancreas cancer treatment: A single Institution experience.
    Shaib, Walid Labib
    Qu, James
    Zhang, Chao
    Ip, Andrew
    Chen, Zhengjia
    El-Rayes, Bassel F.
    Alese, Olatunji
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Neoadjuvant Treatment in Locally Advanced and Borderline Resectable Pancreatic Cancer vs Primary Resectable Pancreatic Cancer
    Del Chiaro, Marco
    Valente, Roberto
    Arnelo, Urban
    [J]. JAMA SURGERY, 2017, 152 (11) : 1057 - 1057
  • [5] Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer
    Scheufele, Florian
    Hartmann, Daniel
    Friess, Helmut
    [J]. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
  • [6] Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcomes at a single academic centre
    Rosello, Susana
    Pizzo, Claudio
    Huerta, Marisol
    Munoz, Elena
    Aliaga, Roberto
    Vera, Almudena
    Alfaro-Cervello, Clara
    Jord, Esther
    Garces-Albir, Marina
    Roda, Desamparados
    Dorcaratto, Dimitri
    Tarazona, Noelia
    Torondel, Sergio
    Guijarro, Jorge
    Sanchiz, Vicente
    Gambardella, Valentina
    Fleitas-Kanonnikoff, Tania
    Lluch, Paloma
    Pascual, Isabel
    Ferrandez, Antonio
    Sabater, Luis
    Cervantes, Andres
    [J]. ESMO OPEN, 2020, 5 (06)
  • [7] Efficacy of Chemoradiation in Locally Advanced (Borderline Resectable and Unresectable) Pancreatic Cancer Remaining Unresectable After Neoadjuvant Chemotherapy
    Weir, J. S.
    McLean, K.
    Henson, C.
    Morton, J.
    Pant, S.
    George, S.
    Aljumaily, R.
    Postier, R.
    Herman, T. S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E198 - E198
  • [8] Neoadjuvant Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
    Kovtun, K.
    Moser, J. A.
    Callery, M.
    Kent, T.
    Tseng, J.
    Miksad, R.
    Bullock, A.
    Schlechter, B.
    Mahadevan, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E198 - E198
  • [9] Effect of Radiotherapy (RT) on Outcomes in Patients (Pts) With Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BRPC, LAPC)
    Thunshelle, C. P.
    Chowdhury, T.
    Zaid, M.
    Jaoude, J. Abi
    Dai, A.
    Kirimli, E.
    Prakash, L.
    Katz, M. H. G.
    Tzeng, C. W.
    Kim, M.
    Wolff, R. A.
    Pant, S.
    Smaglo, B.
    Ludmir, E. B.
    Holliday, E., Jr.
    Das, P.
    Minsky, B. D.
    Taniguchi, C. M.
    Koong, A. C.
    Koay, E. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S147 - S147
  • [10] Toxicity associated with neoadjuvant therapy for borderline resectable pancreatic cancer (BRPC).
    Beg, M. S.
    Olowokure, O. O.
    Ali, S.
    Ahmad, S. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345